Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Riley

Showing results (431-440 of 442) with videos related to

Pageof 45
Sort By:
ESMO Open|July 27, 2025
Circulating tumor DNA mutational landscape and dynamics after progression on a CDK4/6 inhibitor in the PACE phase II trial for metastatic HR-positive/HER2-negative breast cancerR Jeselsohn, J Fu, Y Ren, et al.
Journal of Neuroscience Research|November 27, 2014
Polyethylene glycol-fused allografts produce rapid behavioral recovery after ablation of sciatic nerve segmentsD C Riley, G D Bittner, M Mikesh, et al.
Nature Communications|June 18, 2026
A functional map of phosphoprotein phosphatase regulation identifies an evolutionarily conserved reductase for the catalytic metal ionsBob Meeusen, Sara M Ambjørn, Jiri Veis, et al.
Proceedings. Biological Sciences|July 2, 2024
Phylogenomics recovers multiple origins of portable case making in caddisflies (Insecta: Trichoptera), nature's underwater architectsPaul B Frandsen, Ralph W Holzenthal, Marianne Espeland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2025
Circulating tumor cells dynamics after CDK4/6 inhibitor for hormone-receptor positive metastatic breast cancer: a biomarker analysis from the PACE phase II studyLorenzo Gerratana, Carolina Reduzzi, Yue Ren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2024
PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast CancerErica L Mayer, Yue Ren, Nikhil Wagle, et al.
Pharmaceutical Biology|December 27, 2011
Ethnobotanical approach versus random approach in the search for new bioactive compounds: support of a hypothesisC Gyllenhaal, M R Kadushin, B Southavong, et al.
Critical Ultrasound Journal|November 5, 2016
Pediatric emergency medicine point-of-care ultrasound: summary of the evidenceJennifer R Marin, Alyssa M Abo, Alexander C Arroyo, et al.
Critical Ultrasound Journal|February 5, 2017
Erratum to: Pediatric emergency medicine point-of-care ultrasound: summary of the evidenceJennifer R Marin, Alyssa M Abo, Alexander C Arroyo, et al.
Journal of Natural Products|March 28, 2006
"Studies on biodiversity of Vietnam and Laos" 1998-2005: examining the impactDjaja Doel Soejarto, Hong Jie Zhang, Harry H S Fong, et al.
Pageof 45

Showing results (431-440 of 442) with videos related to

Sort By:
Pageof 45
ESMO Open|July 27, 2025
Circulating tumor DNA mutational landscape and dynamics after progression on a CDK4/6 inhibitor in the PACE phase II trial for metastatic HR-positive/HER2-negative breast cancerR Jeselsohn, J Fu, Y Ren, et al.
Journal of Neuroscience Research|November 27, 2014
Polyethylene glycol-fused allografts produce rapid behavioral recovery after ablation of sciatic nerve segmentsD C Riley, G D Bittner, M Mikesh, et al.
Nature Communications|June 18, 2026
A functional map of phosphoprotein phosphatase regulation identifies an evolutionarily conserved reductase for the catalytic metal ionsBob Meeusen, Sara M Ambjørn, Jiri Veis, et al.
Proceedings. Biological Sciences|July 2, 2024
Phylogenomics recovers multiple origins of portable case making in caddisflies (Insecta: Trichoptera), nature's underwater architectsPaul B Frandsen, Ralph W Holzenthal, Marianne Espeland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2025
Circulating tumor cells dynamics after CDK4/6 inhibitor for hormone-receptor positive metastatic breast cancer: a biomarker analysis from the PACE phase II studyLorenzo Gerratana, Carolina Reduzzi, Yue Ren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2024
PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast CancerErica L Mayer, Yue Ren, Nikhil Wagle, et al.
Pharmaceutical Biology|December 27, 2011
Ethnobotanical approach versus random approach in the search for new bioactive compounds: support of a hypothesisC Gyllenhaal, M R Kadushin, B Southavong, et al.
Critical Ultrasound Journal|November 5, 2016
Pediatric emergency medicine point-of-care ultrasound: summary of the evidenceJennifer R Marin, Alyssa M Abo, Alexander C Arroyo, et al.
Critical Ultrasound Journal|February 5, 2017
Erratum to: Pediatric emergency medicine point-of-care ultrasound: summary of the evidenceJennifer R Marin, Alyssa M Abo, Alexander C Arroyo, et al.
Journal of Natural Products|March 28, 2006
"Studies on biodiversity of Vietnam and Laos" 1998-2005: examining the impactDjaja Doel Soejarto, Hong Jie Zhang, Harry H S Fong, et al.
Pageof 45